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Background: Reports in Asian populations suggest that ethnic and geographical differences may influence
susceptibility to multiple sclerosis (MS) and its clinical behaviors. Here, we sought to retrospectively survey clinical
characteristics and MRI data in Chinese subjects with MS.
Methods: We conducted a retrospective analysis in 117 patients with MS. The patients were divided into
subgroups with optic-spinal form of multiple sclerosis (OSMS; n = 42) and classical multiple sclerosis (CMS; n = 75).
Clinical characteristics, MRI finding and expanded disability status scale (EDSS) score were compared between the
two groups.
Results: In 117 MS patients, 64.1% patients were classified as having CMS and 35.9% OSMS forms. White blood
cell counts of OSMS patients were significantly higher than those of CMS patients (P <0.05). The longitudinal fusion
lesions of spinal cord on MRI were statistically significant between groups (P <0.05). Spinal cord MRI showed that MS
lesions were longer, and revealed spinal cord swelling in patients with CMS, but atrophy in patients with OSMS. The
EDSS score at five years was significantly higher in patients with OSMS than in those with CMS (P <0.05). Relapse rates
of patients with OSMS were also higher than those of patients with CMS (P <0.01) within one to three years.
Conclusions: OSMS accounts for a higher proportion of MS populations in Northern China than in Western countries.
MRI showed a longitudinally extensive spinal cord lesion in patients with OSMS and spinal cord swelling at onset.
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Multiple sclerosis (MS) is an autoimmune disease of the
central nervous system (CNS) characterized by the de-
myelination of white matter. It has been shown that ra-
cial and geographical differences may influence the
susceptibility to MS as well as its manifestations, clinical
characteristics, site of CNS involvement, pathogenesis
and prognosis [1]. Multiple sclerosis is rare in Asian
populations. Previous studies have shown that the incidence
prevalence of MS in populations from Southern China (and
Hong Kong, Taiwan) is low, (0.77 per 100,000 population)
compared to that in Caucasians, with a high female to male
ratio. These studies also showed that in Asia the site of
CNS involvement was more commonly the optic nerve and
spinal cord, and that the condition was characterized by* Correspondence: lizhaoruixin@gmail.com; ltranmd@yeah.net
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reproduction in any medium, provided the orrelatively fast progression, with oligoclonal bands (OB) be-
ing found in the cerebrospinal fluid (CSF) of relatively few
patients [2,3]. In MS populations from Southern China
there is a high degree of spinal cord involvement (66%) [2],
but comparatively little is known about the clinical charac-
teristics of MS in Northern China.
The clinical course of MS can be classified as relapsing-
remitting, primary-progressive, secondary-progressive,
progressive-relapsing, benign and malignant MS forms
[4]. There are thought to be two distinct phenotypes of
relapsing-remitting MS in Asian populations. One is
the conventional form of MS (CMS) that shares similar
genetic and clinical features with the Western type of
MS. The other is optic-spinal form of MS (OSMS), in
which major neurological symptoms derive from optic
neuritis [5]. However, this possibility remains a subject
of controversy. Its clinical course is variable and un-
predictable and its exact etiology is unknown. It ishis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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in Northern China and to identify any distinct clinical and
magnetic resonance imaging (MRI) characteristics of MS in
this population. We, therefore, retrospectively surveyed
clinical data from MS patients presenting to the Chinese
People’s Liberation Army General Hospital and Peking
University People’s Hospital from 2002 to 2009. All pa-
tients included in the analysis were from the Northern
Provinces of the Yangtze River.
Methods
Patients and classification
We conducted a retrospective analysis in 117 patients
with MS (66 female, 51 male; average age 35.9 ± 11.8
years, range 15 to 71 years; average disease duration 3.9 ±
3.6 years, range 0.5 to 26 years). Each had a confirmed diag-
nosis of MS based on the revised McDonald 2005 criteria
[6,7]. Patients with Sjogren’s syndrome, systemic lupus
erythematosus, rheumatoid arthritis, vasculitis, malignancy,
human T-cell leukemia virus type 1 or HIV were excluded
from the analysis.
The patients were classified according to the course of
the disease (relapse-remitting or, primary-progressive) [8]
and the site of lesions. Relapsing-remitting MS was defined
as neurological dysfunction that continued to deteriorate
for at least 24 hours, and then became partially or com-
pletely stabilized, returning to baseline levels within one
month. Primary-progressive (the equivalent of chronic pro-
gressive) MS was defined by progressive deterioration with
no acute changes, over a period of at least six months [9].
Depending on the site of the disease, the patients were di-
vided into optic-spinal or conventional forms of MS [5].
CNS lesions involving the cerebellum and brainstem were
classified as CMS forms. Lesions mainly confined to the
optic nerve and spinal cord lesions were classified as OSMS
forms. Patients with small brain stem lesions were also clas-
sified as OSMS [10].
Neuromyelitis optica (NMO) is an uncommon neu-
roinflammatory syndrome that is distinct from MS.
Differential diagnoses were discussed according to the
multicenter analysis results and diagnostic criteria for neu-
romyelitis optica [11,12]. 1) Serologic antibody NMO-
immunoglobulin G seropositive; 2) onset of NMO with
strong female predilection; 3) NMO is recurrent longitu-
dinally extensive transverse myelitis; 4) patients with NMO
tend to initially present with optic neuritis.
Data analysis
Age, sex, initial clinical symptoms, physical signs, nervous
system site and, if appropriate, the number of relapsing-
remitting episodes were recorded. Results of CSF examin-
ation, including OB examination results, white blood cell
counts, and total protein content were recorded. Evoked
potential data were also included in the analysis. Theexpanded disability status scale (EDSS) was used to evalu-
ate the degree of disability, based on the results of nervous
system examinations [13].
Brain or spinal cord magnetic resonance imaging
examination
Magnetic resonance sequences included conventional T1-
weighted imaging, T2-weighted imaging, fluid-attenuated
inversion recovery (FLAIR) sequence and diffusion-
weighted imaging (DWI). The MRI diagnostic criteria
for MS were those recommended in the European
Magnetic Resonance Imaging in MS (MAGNIMS) pro-
posal [14]. This required intravenous administration
of a gadolinium-containing MR contrast agent, such
as gadolinium-diethylenetriaminepentaacetic acid (Gd-
DTPA), followed by dynamic contrast-enhanced MR
imaging (DCE-MRI) of the brain or spinal cord. High-
field MR images were obtained for all patients using a
1.5 or 3.0 Tesla MR Scanner.
Statistical analysis
Statistical analysis was undertaken using the Statistical
Package for Social Sciences (SPSS version 13.0) software
(IBM Corp., Armonk, NY, USA). Initial symptoms, CFS
fluid examination, MRI studies, evoked potential, the pro-
gress of disability (the EDSS), and relapse frequency were
compared in the CMS and OSMS groups using chi-square
or t tests, two-tailed. P values of less than 0.05 were de-
clared to be significant.
Results
Multiple sclerosis classification and presenting symptoms
Of the 117 MS patients included in the study, 75 (64.1%)
were classified as having CMS, and 42 (35.9%) were clas-
sified as having OSMS forms of MS. Six patients (5%)
had primary progressive MS and 111 patients (95%) had
relapsing-remitting MS.
The most common initial symptoms were physical signs
of weakness (76.9%), sensory loss (66.7%), blurred vision
(56.4%), sphincter dysfunction (43.6%) and paresthesia (see
Table 1).
Cerebrospinal fluid results
White blood cell counts were obtained in CSF of 83 pa-
tients (OSMS n = 24; CMS n = 59). White blood cell
counts of OSMS patients were significantly higher than
those of CMS patients (P = 0.03; Figure 1A).
The CSF protein results were available for 85 patients
(OSMS n = 24; CMS n = 61), who had a lumbar puncture
examination within one month of initial symptoms. The re-
sults indicated that the CSF protein content was higher in
patients with OSMS patients than in those with CMS
patients, but the difference was not statistically significant
(P = 0.43; Figure 1B).
Table 1 Multiple sclerosis (MS) patients initial symptoms
and physical signs
CMS (n = 75) OSMS (n = 42) MS (n = 117)
Sex, F/M 38/37 28/14 66/51
Age, years 35.76 ± 12.23 36.12 ± 11.16 35.89 ± 11.81
Symptoms, n (%)
Weakness 53 (70.7) 37 (88.1) 90 (76.9)
Sensory loss 42 (56.0) 36 (85.7) 78 (66.7)
Paresthesia 15 (20.0) 24 (57.1) 39 (33.3)
Blurred vision 34 (5.3) 32 (76.2) 39 (33.3)
Nystagmus 27 (36.0) 2 (4.7) 29 (24.8)
Ataxia 32 (42.7) 3 (7.1) 35 (29.9)
Sphincter symptoms 20 (26.7) 31 (73.8) 51 (43.6)
Diplopia 8 (10.7) 0 8 (6.8)
Dysarthria 12 (16.0) 0 12 (10.3)
CMS, conventional multiple sclerosis; OSMS, optic-spinal multiple sclerosis; MS,
multiple sclerosis.
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n = 11; CMS n = 3). Five patients with OSMS were OB-
positive (45.45%), and six patients with CMS were OB-
positive (26.07%). There was no significant change of CSF
OB-positive numbers between groups (P = 0.25; Figure 1C).
Magnetic resonance imaging results
Thirty-four patients with OSMS and 29 with CMS under-
went brain and spinal cord MRI examination within one
week of presentation. Thirty-two of the 34 (94.1%) patients
with OSMS and 14 of the 29 (48.2%) patients with CMS
presented with longitudinal fusion of three or more verte-
bral segments and were classified as having extensive spinal
cord lesions, and the lesion difference was statistically
significant (P = 0.002).
All 63 patients with spinal cord lesions underwent Gd-
DTPA-enhanced MRI evaluation. Seventeen patients
with OSMS (50.0%) and 10 patients with CMS (34.5%)
had lesions showing an enhancement pattern.
MRI lesions in patients with CMS were concentrated in
the periventricular, frontal, and parietal deep white matter,
and manifested as round or confluent patch shadows.
Periventricular lesion findings were a vertical distribution,
indicating ‘right-angle’ demyelination. Routine MRI also
detected a few cortical lesions in patients with CMS,
predominantly in the gray matter-white matter junction
(Figure 2A, B). Spinal cord MRI showed that CMS lesions
were longer and showed increased cord swelling at onset.
Lesions showed an abnormal signal, strip or prismatic, un-
clear, paralleling the long axis of the spinal cord (Figure 2C).
Spinal cord MRI showed that OSMS lesions were con-
centrated in the cervical and thoracic spinal cord, and
were distributed along the long axis of the spinal cord.
Spinal cord atrophy was a common feature in patientswith OSMS. T1-weighted images were slightly hypoin-
tense, T2-weighted images were hyperintense showing a
clear boundary, and the images remained hyperintense
during FLAIR and DWI sequences (Figure 3A, B).
Periventricular lesions in patients with CMS are ex-
tended deeply into the white matter, while those in pa-
tients with OSMS are confined to periventricular areas
and brainstem.
In CMS or OSMS, early lesions showed a uniform
nodular structure on enhanced MRI. A few days to sev-
eral weeks later, lesions appeared circular in shape on
enhanced MRI and circular enhancement disappeared
several weeks later. There was rapid changes in lesions
after treatment.
Evoked potential examination results
Nineteen patients with OSMS and 47 with CMS under-
went somatosensory evoked potential (SEP) examin-
ation. Abnormal results were obtained in six patients
(31.7%) with OSMS and in 20 patients (42.6%) with
CMS patients.
Eighteen patients with OSMS and 42 with CMS had
brainstem auditory evoked potential (BAEP) examina-
tions. Two patients (11.1%) with OSMS patients and 12
patients (28.6%) with CMS had abnormal BAEP findings.
Twenty-four patients with 24 OSMS and 50 with CMS
patients had visual evoked potential (VEP) examinations.
VEP findings were abnormal in 16 (56.0%) patients with
OSMS and in 28 (59.5%) patients with CMS.
Progression of disability
Five-year clinical data were available for 12 patients with
OSMS and for 32 patients with CMS. EDSS scores cal-
culated for these patients were significantly higher in pa-
tients with OSMS (2.42 ± 0.90) than in those with CMS
(1.50 ± 0.88; P <0.01).
Relapsing-remitting frequency
The annual relapsing-remitting frequency for the 44 pa-
tients with five-year clinical data is shown in Figure 4. In
both groups there was a tendency for the frequency to
decrease over the five-year observation period. However,
at each time point the relapsing-remitting frequency was
lower in the OSMS group than in the CMS group.
Discussion
Multiple sclerosis (MS) is a common inflammatory auto-
immune neurologic disorder and is the most frequent
cause of nontraumatic neurologic disability in young and
middle-aged adults. The clinical course of MS can be classi-
fied as relapsing-remitting, primary-progressive, secondary-
progressive, progressive-relapsing, benign and malignant
MS forms [4]. There are thought to be two distinct pheno-
types of relapsing-remitting MS in Asian populations. Two
Figure 1 Results of cerebrospinal fluid (CSF) examination, including white blood cell counts, total protein content, and oligoclonal
band (OB). (B) White blood cell count in CSF. The white blood cell counts were significantly higher in patients with optic-spinal multiple sclerosis
(OSMS) patients than in those with conventional multiple sclerosis (CMS) (P <0.05). (B) Total protein content in CSF. The protein content of CSF
was not statistically significant between groups. (C) OB in CSF. The OB of CSF was statistically significant between groups.
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manifest as optic-spinal (OSMS) and conventional (CMS)
forms of MS [5]. Research findings suggest that MS pheno-
types are drastically altered by environmental factors, such
as latitude and ‘Westernization’ [1]. In Asia, the proportion
of MS patients with OSMS is the highest in the world, and
is much higher than in the Caucasian population [15].
Published data also suggest that OSMS is more common in
female patients that CMS, and that the degree of disability
progresses faster, with more relapses, especially in the
first and third years. However, even within Asia, there are
inconsistent incidence reports for CMS and OSMS. In a
series of 1,493 Japanese patients studied in 2009, 57.7%were classified as having CMS and 16.5% were as having
OSMS in [16]. However, in 2006 it was estimated that
OSMS accounted for 56% of Taiwanese patients with
MS [17].
In our population of patients from Northern China,
35.9% had OSMS and 64.1% had CMS. The patients
with OSMS had severe spinal cord lesions and a few
had brain lesions. Only 5% of patients in our study
had primary-progressive MS, which is in accordance
with previously published data [17]. This also contrasts
with Western Caucasian populations, where more
than 30% of MS patients have primary-progressive dis-
ease [18].
Figure 2 Magnetic resonance imaging (MRI) scans from a 31-year-old male patient with conventional multiple sclerosis who presented
with slow reaction times and memory loss for three days. The patient had 97% small lymphocytes in the cerebrospinal fluid (CSF) and
was oligoclonal band positive. (A) Periventricular lesions manifested hyperintense in fluid-attenuated inversion recovery (FLAIR) sequence.
(B) Enhanced MRI T1-weighted image showed uniform nodular, circular lesions. (C) The lesions were also concentrated in the cervical and thoracic spinal
cord, and were distributed along the long axis of the spinal cord and fat-suppressed T2-weighted image remained hyperintense.
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clinical symptom at onset was limb weakness. In the
OSMS group, there were no cases of diplopia or dysarth-
ria, and only two patients had nystagmus. However, sig-
nificantly more patients with OSMS than CMS had
sphincter disorders as a presenting symptom.
White blood cell count in the CFS of the OSMS group
was higher than that of the CMS group. It indicated that
there has been acute inflammatory process and it is a
more urgent task to control inflammation in OSMS pa-
tients. It has previously been reported that CSF protein
levels are significantly higher in patients with OSMS
than in those with CMS [16]. In our patients, CSF pro-
tein levels were numerically higher in the OSMS group
than in the CMS group but the difference was not statis-
tically significant. This finding may be related to the factthat some patients in our study did not have a lumbar
puncture performed within three days of the onset of
presenting symptoms. OBs are also important disease in-
dicators in MS patients with both OSMS and CMS. In
our study, OB testing was not as seen in Caucasian pop-
ulations. Indeed, some studies have speculated that the
differences in occurrence of OB between Eastern and
Western populations may be the consequence of a dif-
ferent immune response of patients with different gen-
etic backgrounds [19-21].
MRI has played a unique role in the diagnosis and
management of MS. In recent years, there have been
considerable changes in the diagnostic criteria for MS as
MRI-based studies have enabled earlier and more accur-
ate diagnosis of the disease [22]. Total brain lesion vol-
ume and spatial distribution of lesions across the brain
Figure 3 Magnetic resonance imaging (MRI) scans from a 29-year-old male patient who presented with a five-week history of numbness and
uncoordinated right upper limb activity for one week. The patient had a nodular cervical spinal cord lesion. (A) T2-weighted imaging showed
hyperintense and (B) enhanced MRI images identified uniform nodular lesions.
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linear lesions and the absence of ovoid lesions are char-
acteristic of OSMS. In addition, longitudinally extensive
spinal cord lesions affecting three or more vertebral seg-
ments are significantly more common in patients with
OSMS than in those with CMS. However, in our study
some of the CMS patients also had longitudinally extensive
spinal cord lesions. These findings suggest that in Asian
populations, longitudinally extensive spinal cord lesions are
heterogeneous between OSMS and CMS patients.
Noninvasive MRI evaluation of the blood–brain barrier
(BBB) is important for monitoring disease progression and
evaluating therapeutic efficacy. MRI enhancement of MS
lesions indicates breakdown of the BBB by active lesions,
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Figure 4 Five-year relapsing-remitting frequency per year in
patients with OSMS (n = 12) and CMS (n = 32).cortical lesions located in the gray matter-white matter
junction of patients with CMS. Other studies have reported
that the presence of cortical lesions confers physical disabil-
ity and cognitive impairment [23].
Evoked potentials assist early diagnosis of MS by de-
tecting subclinical lesions. In our study, results from
high sensitivity VEP tests, and from low sensitivity, was
brainstem auditory evoked potentials were consistent
with patients’ initial symptoms, and indicated minimal
brain stem involvement in most patients.
The most significant clinical feature of MS is that of
relapse. We found that relapse frequency in the first
and third year after clinical onset was significantly
higher in patients with OSMS than in those with CMS.
The relapse frequency was also numerically higher
than in CMS patients in the second, fourth and fifth
years after clinical onset. The degree of disability pro-
gressed faster and was more likely to result in relapse,
emphasizing the importance of early diagnosis and
intervention.Conclusions
In summary, we have shown that OSMS accounts for a
higher proportion of MS patients in Northern China
than in Western countries. In both OSMS and CMS pa-
tients, the most common clinical symptom was limb
weakness at onset. White blood cell count in the CSF of
OSMS patients was high, which may indicate that there
had been an acute inflammatory process. MRI showed a
longitudinally extensive spinal cord lesion in patients
with OSMS.
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